Lumiera Health Inc. (the 'Company' or 'Lumiera') announced the launch of its Awaye pain relief cream in the US market. The first shipment of Awaye has been sent to Amazon.com's distribution center and will soon be available to American consumers. Awaye provides a new generation of relief from acute and chronic pain by exploiting the CB2 receptors of the endocannabinoid system, the body's built-in pain and inflammation defense system.
Awaye is a unique Health Canada approved topical cream that provides relief from pain through complimentary mechanisms of action not found in any other product currently available on the market.